Pharmaceutical Firm Joins Kaluga Tax Base

British-Swiss pharmaceutical giant AstraZeneca said Monday that it will invest $150 million in building its first plant in Russia, joining other foreign drugmakers that have started local production in line with the government’s strategy to reduce dependency on imports.
The Moscow Times